Published in J Mammary Gland Biol Neoplasia on October 01, 2003
Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol (2005) 2.33
Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol (2007) 2.12
Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J (2008) 1.74
Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci U S A (2005) 1.48
Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism. PLoS One (2009) 1.40
Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells? J Cell Sci (2009) 1.27
Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol (2013) 1.26
The EGF repeat and discoidin domain protein, SED1/MFG-E8, is required for mammary gland branching morphogenesis. Proc Natl Acad Sci U S A (2007) 1.22
Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics (2009) 1.21
Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life (2010) 1.12
The extracellular matrix as an adhesion checkpoint for mammary epithelial function. Int J Biochem Cell Biol (2006) 1.09
Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol (2011) 1.07
β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Res (2011) 1.05
Phenotypic heterogeneity of breast cancer stem cells. J Oncol (2011) 1.03
β1 and β4 integrins: from breast development to clinical practice. Breast Cancer Res (2014) 1.00
Control of mammary myoepithelial cell contractile function by α3β1 integrin signalling. EMBO J (2011) 0.99
Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice. Breast Cancer Res (2008) 0.97
Choreographing metastasis to the tune of LTBP. J Mammary Gland Biol Neoplasia (2011) 0.90
Interconnected contribution of tissue morphogenesis and the nuclear protein NuMA to the DNA damage response. J Cell Sci (2012) 0.90
Integrin signaling in mammary epithelial cells and breast cancer. ISRN Oncol (2012) 0.88
P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget (2014) 0.87
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells. Breast Cancer Res Treat (2010) 0.87
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat (2009) 0.82
Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis. J Cell Mol Med (2008) 0.81
Microenvironmental control of the breast cancer cell cycle. Anat Rec (Hoboken) (2012) 0.80
CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling. BMC Cancer (2014) 0.79
Association between polymorphisms in the integrin gene predicted microRNA binding sites and bladder cancer risk. Int J Clin Exp Med (2014) 0.77
The contribution of adhesion signaling to lactogenesis. J Cell Commun Signal (2010) 0.75
The Acinar Cage: Basement Membranes Determine Molecule Exchange and Mechanical Stability of Human Breast Cell Acini. PLoS One (2015) 0.75
Integrins in development and cancer. Biophys Rev (2013) 0.75
Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. J Cell Biol (2004) 3.06
Epithelial-mesenchymal transitions: insights from development. Development (2012) 2.58
Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol (2008) 2.46
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis (2007) 2.41
Regional copy number-independent deregulation of transcription in cancer. Nat Genet (2006) 2.33
Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol (2006) 2.32
Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res (2003) 2.30
Johnson-Kendall-Roberts theory applied to living cells. Phys Rev Lett (2005) 2.13
Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res (2009) 2.05
Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development (2002) 1.99
Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage. Development (2005) 1.88
Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation (2003) 1.85
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet (2005) 1.74
Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol (2006) 1.59
Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development (2004) 1.58
The human tissue plasminogen activator-Cre mouse: a new tool for targeting specifically neural crest cells and their derivatives in vivo. Dev Biol (2003) 1.56
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b. Carcinogenesis (2005) 1.54
Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene (2005) 1.50
Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes. Development (2006) 1.49
Identification of the mammary line in mouse by Wnt10b expression. Dev Dyn (2004) 1.40
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med (2013) 1.38
The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep (2008) 1.36
Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res (2013) 1.36
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Clin Cancer Res (2008) 1.30
SnapShot: The epithelial-mesenchymal transition. Cell (2011) 1.28
Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci (2012) 1.27
Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains. J Biol Chem (2005) 1.20
The importance of being a myoepithelial cell. Breast Cancer Res (2002) 1.20
Screening therapeutic EMT blocking agents in a three-dimensional microenvironment. Integr Biol (Camb) (2013) 1.17
α-Catenin and vinculin cooperate to promote high E-cadherin-based adhesion strength. J Biol Chem (2012) 1.14
Dermal fin rays and scales derive from mesoderm, not neural crest. Curr Biol (2013) 1.11
Adhesion within the stem cell niches. Curr Opin Cell Biol (2009) 1.10
The mammary myoepithelial cell. Int J Dev Biol (2011) 1.08
A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. PLoS One (2012) 1.06
Separation force measurements reveal different types of modulation of E-cadherin-based adhesion by nectin-1 and -3. J Biol Chem (2004) 1.05
Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. Cancer Res (2005) 1.05
EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties. J Cell Biol (2002) 1.03
Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Curr Drug Targets (2012) 1.03
Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation. Mol Cancer (2005) 1.02
Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept. Adv Drug Deliv Rev (2011) 1.01
YY1 regulates the neural crest-associated slug gene in Xenopus laevis. J Biol Chem (2004) 1.00
Changes in cholesterol levels in the plasma membrane modulate cell signaling and regulate cell adhesion and migration on fibronectin. Cell Motil Cytoskeleton (2007) 0.99
Control of mammary myoepithelial cell contractile function by α3β1 integrin signalling. EMBO J (2011) 0.99
Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma. Int J Cancer (2013) 0.98
Breast cancer progression with a Twist. Nat Med (2004) 0.98
Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis. PLoS One (2012) 0.98
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol Biol Cell (2002) 0.97
Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis. Mol Cancer (2013) 0.96
Myoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice. J Mammary Gland Biol Neoplasia (2005) 0.94
Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells (2012) 0.94
EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction. Autophagy (2013) 0.93
An exclusively mesodermal origin of fin mesenchyme demonstrates that zebrafish trunk neural crest does not generate ectomesenchyme. Development (2013) 0.92
Wnt11r is required for cranial neural crest migration. Dev Dyn (2008) 0.92
The proto-oncogene Myc is essential for mammary stem cell function. Stem Cells (2012) 0.91
Microfluidic cell trap array for controlled positioning of single cells on adhesive micropatterns. Lab Chip (2013) 0.90
Regulation of XSnail2 expression by Rho GTPases. Dev Dyn (2007) 0.89
α-catenin, vinculin, and F-actin in strengthening E-cadherin cell-cell adhesions and mechanosensing. Cell Adh Migr (2013) 0.89
Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer. Am J Cancer Res (2013) 0.88
Translating metastasis-related biomarkers to the clinic--progress and pitfalls. Nat Rev Clin Oncol (2013) 0.88
A nonneural epithelial domain of embryonic cranial neural folds gives rise to ectomesenchyme. Proc Natl Acad Sci U S A (2008) 0.88
Cell delamination in the mesencephalic neural fold and its implication for the origin of ectomesenchyme. Development (2013) 0.86
Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. Stem Cells (2013) 0.86
Integrins in mammary development. Semin Cell Dev Biol (2012) 0.82
[Mammary gland development: Role of basal myoepithelial cells]. J Soc Biol (2006) 0.82
Loss of CD24 expression promotes ductal branching in the murine mammary gland. Cell Mol Life Sci (2010) 0.82
Differential expression of beta3 integrin gene in chick and mouse cranial neural crest cells. Dev Dyn (2003) 0.81
beta-Catenin regulates P-cadherin expression in mammary basal epithelial cells. FEBS Lett (2007) 0.81